|
Medtronic Defibrillator Leads Recalled
- Increased risk of cardiovascular events
- Increased risk of Heart Attacks
On October 15, 2007 Medtronic, a manufacturer of implantable defibrillators,
has recalled the Sprint Fidelis leads (electrodes) used in its products.
Additionally, the company recommends against new implants of the
leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949). Medtronic
has identified five patient deaths in which a Sprint Fidelis lead
failure may have been a likely or contributing cause in that death.
If you or someone you know has suffered an injury or has required
replacement of an Implantable Cardiover Defibrillators (ICD's) or
Cardiac Resynchronization Therapy Defibrillators (CRT-D's) or the
Sprint Fidelis Leads, or simply if they have a Sprint Fidelis lead
implanted in them, they should contact their physician at once.
Learn more about your options and get an instant
answer to your questions. Call today and speak with an Attorney:
1.800.838.0800.
|
$1.5 Million: Over the counter Pharmacy
cases. Two cases involving an over the counter drug. 2004
$5+ Million: Multiple pharmacy cases.
Involving damage caused by a prescription drug. 2004
"I was amazed at how the team at Burke and Eisner was able
to cut through it all, and successfully obtain the highest possible
compensation for my losses."
(NH Client)
FDA:
Medtronic Recalls Sprint Fidelis Cardiac Leads - Questions and Answers
for Consumers
FDA: Class
1 Recall: Medtronic Inc. Sprint Fidelis® Defibrillator Leads
FDA: Statement
on Medtronic's Voluntary Market Suspension of Their Sprint Fidelis
Defibrillator Leads
|
